Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €82.00 ($95.35) price objective by equities researchers at Jefferies Financial Group in a note issued to investors on Tuesday. The brokerage presently has a “neutral” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 19.19% from the company’s previous close.

A number of other analysts have also recently weighed in on the stock. Goldman Sachs Group set a €88.00 ($102.33) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a report on Friday. UBS Group set a €82.00 ($95.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Friday. Kepler Capital Markets set a €100.00 ($116.28) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Thursday, October 18th. Deutsche Bank set a €107.00 ($124.42) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Thursday, October 18th. Finally, Cfra set a €78.00 ($90.70) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Wednesday, October 17th. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of €92.13 ($107.13).

ETR:FME opened at €68.80 ($80.00) on Tuesday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Article: What is the yield curve?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.